10-Q: MSP Recovery Grapples with Going Concern, Nasdaq Delisting

MSP Recovery, Inc. reported a substantial net loss and negative equity for the six months ended June 30, 2025, raising significant doubt about its ability to continue as a going concern and facing potential Nasdaq delisting.

Summary

• Reported a net loss of $477.8 million for the six months ended June 30, 2025, an increase from $388.4 million in the prior year period.
• Net loss attributable to MSP Recovery, Inc. shareholders significantly worsened to $264.8 million from $44.0 million year-over-year.
• Total revenues decreased by 78% to $1.4 million for the six months ended June 30, 2025, compared to $6.3 million in the prior year.
• The company has concluded there is substantial doubt about its ability to continue as a going concern, with unrestricted cash of $4.0 million as of June 30, 2025, and $2.1 million as of July 31, 2025.
• Received a Nasdaq notice on April 24, 2025, for non-compliance with the minimum stockholders' equity requirement, with a deficit of $128.4 million against a $2.5 million minimum. A plan was submitted on June 5, 2025.
• The Yorkville SEPA is currently the sole source of short-term liquidity, with recent amendments reducing the conversion floor price to $0.50 and increasing advances by up to $3.0 million.
• Corporate restructuring agreements with Hazel and Virage were terminated in May and June 2025, respectively.
• Ongoing SEC and USAO investigations, along with re-commenced litigation with Cano Health and a new shareholder class action lawsuit.

Sentiment

Score: 2

Explanation: The company is in severe financial distress, explicitly stating 'substantial doubt about its ability to continue as a going concern.' It reported significant and worsening net losses, negative equity, and declining cash reserves. The Nasdaq delisting threat, termination of key restructuring agreements, and ongoing regulatory investigations further compound the negative outlook, indicating a high risk of insolvency or bankruptcy.

Positives

• Claims recovery income increased by $0.2 million to $0.5 million for the three months ended June 30, 2025, compared to the same period in the prior year, driven by increased settlements.
• General and administrative expenses decreased by $1.9 million (30%) for Q2 2025 and $2.1 million (18%) for H1 2025, primarily due to reductions in payroll and information technology expenses.
• Professional fees decreased by $2.2 million (51%) for Q2 2025 and $4.1 million (47%) for H1 2025, mainly from lower corporate legal, accounting, and consulting fees.
• Professional fees legal decreased by $3.5 million (100%) for Q2 2025 and $6.5 million (94%) for H1 2025, due to the completion of Law Firm advance amortization.
• Yorkville SEPA floor price reduced from $3.75 to $0.50, potentially easing future equity conversions for liquidity.
• Yorkville agreed to increase advances by up to $3.0 million, with $2.1 million funded by August 8, 2025, providing some short-term liquidity.
• Maturity date of Yorkville Convertible Notes extended to November 30, 2026.

Negatives

• Net loss for the six months ended June 30, 2025, was $477.8 million, a 23% increase from $388.4 million in the prior year.
• Net loss attributable to MSP Recovery, Inc. shareholders significantly increased by 502% to $264.8 million for the six months ended June 30, 2025, from $44.0 million in the prior year.
• Total revenues decreased by 78% to $1.4 million for the six months ended June 30, 2025, compared to $6.3 million in the prior year.
• Unrestricted cash balance significantly declined to $4.0 million as of June 30, 2025, and further to $2.1 million as of July 31, 2025.
• Total liabilities increased to $2,277.9 million as of June 30, 2025, from $2,047.5 million as of December 31, 2024.
• Total stockholders' equity is a deficit of $604.0 million as of June 30, 2025, worsening from a deficit of $128.4 million as of December 31, 2024.
• Substantial doubt about the company's ability to continue as a going concern.
• Non-compliance with Nasdaq's minimum stockholders' equity requirement ($128.4 million deficit vs. $2.5 million minimum).
• Working Capital Credit Facility and Operational Collection Floor are fully utilized with no remaining funding capacity.
• Corporate restructuring agreements with Hazel and Virage were terminated, indicating failed attempts to secure additional financing or restructure obligations.
• Interest expense increased by $43.6 million (22%) to $243.5 million for the six months ended June 30, 2025, compared to the prior year.
• Claims amortization expense remains very high at $237.3 million for the six months ended June 30, 2025.
• The company has not generated substantial revenue from its claims portfolio to date.

Risks

• Substantial doubt about the ability to continue as a going concern due to recurring losses, negative cash flows, and dependence on uncertain future funding.
• Risk of delisting from Nasdaq Capital Market due to non-compliance with minimum stockholders' equity requirements.
• Reliance on the Yorkville SEPA as the sole source of short-term liquidity; if Yorkville is unwilling or unable to provide funds, insolvency or bankruptcy may occur.
• Ongoing SEC investigation and USAO grand jury investigation, which could lead to material adverse developments.
• Uncertainty regarding the outcome of re-commenced litigation with Cano Health, including a $5.0 million receivable that has been reserved.
• Exposure to a putative class action shareholder lawsuit alleging fiduciary-duty breaches and unjust enrichment.
• The Eleventh Circuit's ruling on a four-year statute of limitations for MSP Act claims could render certain claims unrecoverable and reduce Paid Value of Potentially Recoverable Claims (PVPRC) by an estimated $10.8 billion.
• Ability to generate future revenue is significantly dependent on factors outside the company's control, including changes to the MSP Act.
• Inability to attract new Assignors to the platform could adversely affect future profitability.
• The company's business model is dependent on achieving substantial revenue from its claims portfolio in the future, which has not occurred to date.
• Inability to recover the up-front purchase price from assigned claims or investments made in pursuing recoveries would adversely affect profitability.

Future Outlook

The company faces substantial doubt about its ability to continue as a going concern, with liquidity dependent on its ability to raise additional funds or generate substantial revenue, the timing and amount of which are uncertain. Management is taking steps to raise additional funds but provides no assurances of success. The company also needs to file additional registration statements with the SEC to sell more shares to Yorkville, with no assurances of timing or effectiveness. The outcome of ongoing legal and regulatory investigations remains uncertain, and a proposed reverse stock split aims to maintain Nasdaq listing compliance.

Management Comments

• The Company has concluded that there is substantial doubt about its ability to continue as a going concern.
• Unless we are successful in raising additional funds through the offering of debt or equity securities, we have concluded it is probable we will be unable to continue to operate as a going concern.
• Management is taking steps to raise additional funds to address its operating and financial cash requirements to continue operations. There are no assurances the Company will receive the necessary funding or generate revenue necessary to fund operations.
• The Company believes that the investigations will be resolved without any material developments; however, there can be no assurance as to the outcome or future direction thereof.
• The Company intends to vigorously assert its position in all Cano related litigation.
• The defendants intend to vigorously defend their position in the Shareholder Litigation.

Industry Context

MSP Recovery operates in the healthcare reimbursement recovery and data analytics sector, focusing on identifying and recovering improper payments for Medicare, Medicaid, and commercial health insurers. The company highlights the complexity and fragmentation of the healthcare system, estimating a serviceable market of over $161.5 billion annually, with health spending projected to grow at 5.6% a year. Its business model relies on proprietary algorithms and irrevocable assignments of claims, differentiating it from competitors by assuming direct litigation risk and pursuing double damages under the Medicare Secondary Payer Act. New platforms like Chase to Pay and the MSP/Palantir Clearinghouse aim to leverage AI and machine learning to improve payment accuracy and resolve liens, addressing systemic issues in healthcare reimbursement.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess the company's performance against global benchmarks or industry peers.
• The company's business model, which involves irrevocable assignment of claims and direct litigation, is described as unique, making direct comparisons challenging based solely on the provided information.
• The company's 'Recovery Multiple' KPI is noted to have 'limited utility for historical periods' due to limited actual recoveries, further hindering direct comparison to industry recovery rates.

Corporate Governance

Legal Proceedings

• Ongoing SEC investigation initiated August 11, 2022, with multiple subpoenas issued, including to company officers in June and July 2025, regarding the Business Combination, financial results, investor agreements, and data analytics platforms.
• Ongoing U.S. Attorneys Office (USAO) grand jury investigation initiated March 10, 2023, with subpoenas requesting information on proprietary algorithms, stock price drop, and marketing materials.
• Re-commenced litigation with Cano Health, LLC, following the lifting of bankruptcy stay, involving mutual lawsuits for breach of contract, fraud, and declaratory relief, with a $5.0 million receivable from Cano reserved due to its bankruptcy.
• Putative class action shareholder lawsuit filed May 7, 2025, alleging fiduciary-duty breaches and unjust enrichment against Lionheart Equities, LLC and certain current/former directors and officers.

Related Party Transactions

• Unsecured promissory note of $112.8 million to MSP Principals (John H. Ruiz and Frank C. Quesada), bearing 4% annual interest, maturing June 16, 2026.
• Additional $13.0 million contributed by MSP Principals at the merger date, maturing October 31, 2026.
• Law Firm (owned by CEO John H. Ruiz) had advances for operating expenses terminated on April 14, 2025; any future compensation will first repay advanced funds.
• Payable to the Law Firm of $1.2 million and a receivable from the Law Firm of $0.9 million as of June 30, 2025.
• $0.2 million receivable from MSP Recovery Aviation, LLC, and $0.1 million payable to MSP Aviation as of June 30, 2025.
• $19.8 million due to affiliates and a $0.5 million note payable with Series MRCS as of June 30, 2025.
• Interest expense of $179.1 million for the six months ended June 30, 2025, related to the VRM Full Return and Virage MTA Amendment with VRM MSP (a related party).
• MSP Principals pledged equity interests and real property, and provided personal guaranties, as additional collateral for the Hazel Working Capital Credit Facility, with the amount increased by $3.25 million to $17.25 million on April 1, 2025.

Stakeholder Impact

• Shareholders: Face significant risk of substantial loss of investment due to recurring net losses, negative equity, and the 'going concern' warning. Potential for further dilution from equity raises (Yorkville SEPA) and a proposed reverse stock split. Risk of delisting from Nasdaq could severely impact liquidity and share value. Subject to a class action lawsuit.
• Creditors (e.g., Yorkville, Nomura, Hazel, Virage, MSP Principals): Exposed to significant credit risk given the company's financial distress and 'going concern' status. While some obligations are secured by claims proceeds or collateral, the ability to fully recover is uncertain. Restructuring agreements with Hazel and Virage were terminated, indicating challenges in managing debt obligations.
• Employees: Potential for job insecurity and impact on morale due to the company's financial instability and 'going concern' status.
• Customers (Assignors): While the company's business model involves irrevocable assignments of claims, the company's financial health and ongoing legal issues could impact its ability to effectively pursue recoveries, potentially affecting assignors' expected proceeds.
• Regulatory Bodies (SEC, USAO): Actively investigating the company, which could lead to penalties, fines, or other enforcement actions, further impacting the company's operations and financial standing.

Next Steps

• Regain compliance with Nasdaq's minimum stockholders' equity requirement by October 21, 2025 (if extension granted).
• Hold a Special Meeting on August 18, 2025, to vote on a reverse stock split proposal (ratio between 1-for-2 and 1-for-7) to maintain Nasdaq listing.
• File additional registration statements with the SEC to register more shares for resale to Yorkville under the SEPA.
• Continue deploying legal strategies to mitigate the impact of the Eleventh Circuit's statute of limitations ruling on claims recoverability.
• Vigorously defend against the re-commenced Cano Health litigation and the new shareholder class action lawsuit.
• Management is taking steps to raise additional funds to address operating and financial cash requirements.

Key Dates

Recommendation

MSP Recovery, Inc. is in a precarious financial position, explicitly stating 'substantial doubt about its ability to continue as a going concern.' The company reported a significant and worsening net loss of $477.8 million for the first half of 2025, a negative equity of $604.0 million, and critically low unrestricted cash of $2.1 million as of July 31, 2025. It faces an imminent threat of Nasdaq delisting due to non-compliance with minimum equity requirements. Key restructuring agreements with Hazel and Virage have been terminated, and the company's sole short-term liquidity source, the Yorkville SEPA, requires further SEC registration and has seen its conversion floor price drastically reduced, indicating severe financial strain and potential for significant shareholder dilution. Ongoing SEC and USAO investigations, coupled with re-commenced litigation and a new shareholder lawsuit, add substantial legal and regulatory uncertainty. Given the severe financial distress, high operational risks, and lack of clear path to profitability, a 'strong sell' recommendation is warranted for investors to mitigate further potential losses.

Keywords

MSP Recovery, Healthcare Reimbursement, Data Analytics, SEC Filing, 10-Q, Going Concern, Nasdaq Delisting, Legal Proceedings, Claims Recovery, Yorkville SEPA, Financial Performance, Net Loss, Liquidity, Corporate Governance, Medicare Secondary Payer Act, AI, Machine Learning, EHR